IBB

Biotech ETFs Could Be in for More Pain Ahead

Biotech ETFs Could Be in for More Pain Ahead

By Max ChenMay 2, 2022

ETF Building Blocks Channel

Positioning for Biotech Bounceback

Positioning for Biotech Bounceback

By Tom LydonApril 1, 2022

ETF Building Blocks Channel

Make Biotech Cash Considerations With SBIO

Make Biotech Cash Considerations With SBIO

By Tom LydonMarch 28, 2022

Investors Should Take a Look at the Beaten Down Biotech ETFs

Investors Should Take a Look at the Beaten Down Biotech ETFs

By Max ChenMarch 18, 2022

ETF Building Blocks Channel

Get Ready for a Biotech ETF Comeback

Get Ready for a Biotech ETF Comeback

By Elle CarusoFebruary 17, 2022

Biotech ETFs Muddled Despite Amgen Strength

Biotech ETFs Muddled Despite Amgen Strength

By Max ChenFebruary 8, 2022

ETF Building Blocks Channel

Small-Cap Biotech Opportunity Knocks

Small-Cap Biotech Opportunity Knocks

By Tom LydonFebruary 1, 2022

ETF Building Blocks Channel

Consolidation Could Come Calling for Biotech in 2022

Consolidation Could Come Calling for Biotech in 2022

By Tom LydonJanuary 5, 2022

ETF Building Blocks Channel

Biotech M&A Could Finally Perk Up in 2022

Biotech M&A Could Finally Perk Up in 2022

By Tom LydonDecember 27, 2021

ETF Building Blocks Channel

Smaller Biotech Stocks Ready to Perk Up

Smaller Biotech Stocks Ready to Perk Up

By Tom LydonDecember 7, 2021

Innovative ETFs Channel

Moderna's Omicron Booster Strategy Lifts Biotechnology ETFs

Moderna’s Omicron Booster Strategy Lifts Biotechnology ETFs

By Max ChenNovember 29, 2021

ETF Building Blocks Channel

Memeification of Biotech Stocks Shines Light on This ETF

Memeification of Biotech Stocks Shines Light on This ETF

By Tom LydonNovember 24, 2021

Innovative ETFs Channel

Pfizer's Covid-19 Pill Has Mixed Results for Healthcare ETFs

Pfizer’s COVID-19 Pill Has Mixed Results for Healthcare ETFs

By Max ChenNovember 5, 2021

ETF Building Blocks Channel

Biotech Ready to Participate in Healthcare Bullishness

Biotech Ready to Participate in Healthcare Bullishness

By Tom LydonOctober 29, 2021

ETF Building Blocks Channel

Legend Biotech Hits New 54-Week High

Legend Biotech Hits New 54-Week High

By Parker DoyleOctober 13, 2021

Could Biotech ETFs Be Due For More Upside?

Could Biotech ETFs Be Due For More Upside?

By Ian YoungOctober 8, 2021

ETF Building Blocks Channel

Drug Price Debate May Not Hinder Biotech ETFs After All

Drug Price Debate May Not Hinder Biotech ETFs After All

By Tom LydonSeptember 16, 2021

ETF Building Blocks Channel

Biotech Stocks Have Colds, but They Can Heal

Biotech Stocks Have Colds, but They Can Heal

By Tom LydonSeptember 13, 2021